adverse events

4:14
Evaluation of costs associated with AEs in urothelial cancer patients
Petros Grivas
1:30
AdRad safety results: radium-233/VMAT RT in the first-line for metastatic prostate cancer
Joe O'Sullivan
1:46
Adverse events in bladder cancer immunotherapy
Jonathan Rosenberg
1:41
Avoiding chemotherapy in the treatment of breast cancer
Peter Fasching
1:10
Optimizing treatment for renal cell carcinoma with sequential therapies
Robert Figlin
2:19
Chemotherapy vs. immunotherapy for the treatment of Merkel cell carcinoma
Paul Nghiem
3:08
Improved survival, toxicity & QoL with pembrolizumab in head and neck cancer
Kevin Harrington
3:39
VXM01 vaccine in progressive glioblastoma: final results
Wolfgang Wick
0:54
Can checkpoint inhibitors combinations replace single agent drugs?
Christopher Campen
1:03
Guiding clinicians to recognize toxicity levels of newer immunotherapy agents
Christopher Campen
1:58
Managing the adverse events of immune checkpoint inhibitors
Christopher Campen
3:07
Vinflunine shows a chemotherapeutic advantage for locally-advanced and metastatic penile cancer
Lisa Pickering
2:13
Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
Neal Shore
1:31
The nurse’s perspective on caring for lung cancer patients receiving immunotherapy
Rachel Thomas
2:02
Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma
Axel Hauschild
6:26
ESMO 2016: Press brief on results of CABOSUN trial cabozantinib compared to sunitinib in RCC
Toni Choueiri
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals